We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

Warner Chilcott Settlement Underscores Risks in Manufacturer Relationships with Healthcare Providers and Reimbursement Support Programs

09 November 2015

Health Alert

On October 29, 2015, the U.S. Department of Justice (DOJ) announced a global settlement with Warner Chilcott U.S. Sales LLC, a subsidiary of pharmaceutical manufacturer Warner Chilcott, based on conduct in violation of criminal healthcare fraud statutes and the civil False Claims Act.



Read more: Warner Chilcott Settlement Underscores Risks in Manufacturer Relationships with Healthcare Providers and Reimbursement Support Programs

The team

Loading data